Cargando…
Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
In the emerging era of cancer immunotherapy, immune checkpoint blockades (ICBs) and adoptive cell transfer therapies (ACTs) have gained significant attention. However, their therapeutic efficacies are limited due to the presence of cold type tumors, immunosuppressive tumor microenvironment, and immu...
Autores principales: | Lee, Kyu-Won, Yam, Judy Wai Ping, Mao, Xiaowen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486560/ https://www.ncbi.nlm.nih.gov/pubmed/37681880 http://dx.doi.org/10.3390/cells12172147 |
Ejemplares similares
-
Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants
por: Bouazzaoui, Abdellatif, et al.
Publicado: (2021) -
An update on the role of complement in hepatocellular carcinoma
por: Xiao, Zhijie, et al.
Publicado: (2022) -
Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103(+) conventional dendritic cells
por: Zhou, Yifan, et al.
Publicado: (2020) -
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
por: Calmeiro, João, et al.
Publicado: (2020) -
From Exosome Biogenesis to Absorption: Key Takeaways for Cancer Research
por: Lau, Nicolas Cheuk Hang, et al.
Publicado: (2023)